Simon P Watkins

5PUBLICATIONS
16CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 16, 2023
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.

Karim Fizazi, Josep M Piulats, M Neil Reaume

|Jun 23, 2022
A Case Study of Clinical Response to Rucaparib in a Patient with Metastatic Castration-Resistant Prostate Cancer and a <i>RAD51B Alteration</i>.

Brieuc Sautois, Andrea Loehr, Simon P Watkins

|Oct 02, 2021
Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study.

Andrea Loehr, Akash Patnaik, David Campbell

|Feb 09, 2021
Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.

Hanna Tukachinsky, Russell W Madison, Jon H Chung

|Feb 23, 2020
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.

Wassim Abida, David Campbell, Akash Patnaik

Pageof 1

Frequent Collaborators

3 joint publications

Alan H Bryce

3 joint publications

Andrew Simmons

3 joint publications

Tony Golsorkhi

2 joint publications

Nicholas J Vogelzang